# DM-CHOC-PEN for Brain Tumors in AYA Subjects

> **NCT03668847** · PHASE2 · COMPLETED · sponsor: **DEKK-TEC, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Advanced Cancer
- Brain Metastases

## Interventions

- **DRUG:** DM-CHOC-PEN

## Key facts

- **NCT ID:** NCT03668847
- **Lead sponsor:** DEKK-TEC, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03668847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03668847, "DM-CHOC-PEN for Brain Tumors in AYA Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03668847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*